Mersana Therapeutics, Inc. (NASDAQ:MRSN) Not Doing Enough For Some Investors As Its Shares Slump 34%
Mersana Therapeutics, Inc. (NASDAQ:MRSN) shares have had a horrible month, losing 34% after a relatively good period beforehand.
Simply Wall StApr 26 06:32 ET
Why Teledyne Technologies Shares Are Trading Lower By 9%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Shares of Teledyne Technologies Incorporated (NYSE:TDY) fell sharply during Wednesday's session after the company reported worse-than-expected first-quarter financial results and cut FY24 adjusted EPS guidance.
BenzingaApr 24 13:57 ET
Mersana Therapeutics (NASDAQ:MRSN Investor Three-year Losses Grow to 80% as the Stock Sheds US$68m This Past Week
While not a mind-blowing move, it is good to see that the Mersana Therapeutics, Inc. (NASDAQ:MRSN) share price has gained 20% in the last three months. But the last three years have seen a terrible
Simply Wall StApr 20 08:06 ET
Express News | Mersana Therapeutics Inc : Citigroup Raises Target Price to $6 From $5
Moomoo 24/7Apr 12 06:32 ET
Mersana Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
CAMBRIDGE, Mass., April 04, 2024 (GLOBE NEWSWIRE) -- Mersana Therapeutics, Inc. (NASDAQ:MRSN), a clinical-stage biopharmaceutical company focused on discovering and developing a pipeline of antibody-drug conjugates
GlobeNewswireApr 4 16:30 ET
The Analyst Verdict: Mersana Therapeutics In The Eyes Of 5 Experts
5 analysts have shared their evaluations of Mersana Therapeutics (NASDAQ:MRSN) during the recent three months, expressing a mix of bullish and bearish perspectives.The following table encapsulates the
BenzingaMar 19 09:00 ET
Express News | JP Morgan Upgrades Mersana Therapeutics to Neutral, Announces $5 Price Target
Moomoo 24/7Mar 19 05:50 ET
12 Health Care Stocks Moving In Friday's After-Market Session
GainersCue Health (NASDAQ:HLTH) shares increased by 12.1% to $0.22 during Friday's after-market session. The company's market cap stands at $34.8 million. As per the press release, Q4 earnings came ou
BenzingaMar 15 17:33 ET
AVLX, SGH and ETNB Are Among Pre Market Losers
Seeking AlphaMar 15 16:48 ET
Mersana Therapeutics (MRSN) Gets a Buy From Truist Financial
TipRanksMar 12 08:37 ET
Top 10 Best Performing Biotech Stocks of 2024 so Far
Seeking AlphaMar 6 11:25 ET
Earnings Call: Mersana Therapeutics Reports on ADC Development Progress
InvestingMar 1 04:44 ET
Buy Rating Affirmed for Mersana Therapeutics Amid Promising ADC Developments and Upcoming Milestones
TipRanksMar 1 01:07 ET
Express News | Mersana Therapeutics Shares Are Trading Higher After Multiple Analysts Upgraded the Stock
Moomoo 24/7Feb 29 14:18 ET
Hormel Foods Reports Upbeat Earnings, Joins Pure Storage, Okta, Papa John's International And Other Big Stocks Moving Higher On Thursday
U.S. stocks were higher, with the Nasdaq Composite gaining around 50 points on Thursday. Shares of Hormel Foods Corporation (NYSE:HRL) rose sharply during Thursday's session after the company reporte
BenzingaFeb 29 11:30 ET
Expert Outlook: Mersana Therapeutics Through The Eyes Of 5 Analysts
Ratings for Mersana Therapeutics (NASDAQ:MRSN) were provided by 5 analysts in the past three months, showcasing a mix of bullish and bearish perspectives.The following table summarizes their recent ra
BenzingaFeb 29 11:00 ET
Mersana Therapeutics Analyst Ratings
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 02/29/2024 17.15% Wedbush $2 → $7 Upgrades Neutral → Outperform 02/29/2024 50.63% Truist Securities $9 → $
BenzingaFeb 29 10:49 ET
Mersana Therapeutics Price Target Maintained With a $9.00/Share by Truist Securities
Mersana Therapeutics Price Target Maintained With a $9.00/Share by Truist Securities
Dow JonesFeb 29 09:13 ET
Express News | Baird Maintains Neutral on Mersana Therapeutics, Raises Price Target to $5
Moomoo 24/7Feb 29 07:17 ET
Mersana Therapeutics Raised to Buy From Neutral by Guggenheim
Mersana Therapeutics Raised to Buy From Neutral by Guggenheim
Dow JonesFeb 29 06:07 ET
No Data
No Data